TQH2929

· Chia Tai Tianqing Pharmaceutical Group; Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TQH2929, covering 2025-03-25 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis [Phase 2]